Relations du système plasminogène-plasmine et cancer: Étude moléculaire de facteurs liés à l’invasivité et à la néoangiogenèse. PAI1, PAI2, uPA, uPAR valeur pronostique et cibles thérapeutiques potentielles

Author： Martin P.-M.   Dussert C.   Romain S.   Ouafik L.H.  

Publisher： Springer Publishing Company

ISSN： 1292-3818

Source： Oncologie, Vol.12, Iss.5-6, 2010-06, pp. : 322-340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

uPA/PAI-1 expression and uPA promoter methylation in meningiomas

By Kandenwein Julia   Park-Simon Tjoung-Won   Schramm Johannes   Simon Matthias  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 533-539

Springer Publishing Company

Access to resources Recommend Favorite

High levels of uPA and PAI-1 predict a good response to anthracyclines

By Borstnar Simona  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 615-624

Springer Publishing Company

Access to resources Recommend Favorite

High levels of uPA and PAI-1 predict a good response to anthracyclines

By Pritchard Kathleen  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 625-626

Springer Publishing Company

Access to resources Recommend Favorite

Tumor-Associated Proteolytic Factors uPA and PAI-1 in Endometrial Carcinoma

By Kohler U.   Hiller K.   Martin R.   Langanke D.   Naumann G.   Bilek K.   Janicke F.   Schmitt M.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 268-274

Elsevier

Access to resources Recommend Favorite

Immunoassays of urokinase (uPA) and its type-1 inhibitor (PAI-1) in detergent extracts of breast cancer tissue

By Pedersen A.N.   Mouridsen H.T.   Tenney D.Y.   Brunner N.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 899-908

Elsevier

Access to resources Recommend Favorite